The Roskamp Institute is pleased to announce that its second annual seminar, Grey Matters—A Symposium on Alzheimer’s Disease Research, is nearly sold out. “We are thrilled with the outpouring of support for our Grey Matters event. The level of interest speaks to the...

A research project at The Roskamp Institute has demonstrated for the first time that mild Traumatic Brain Injury (mTBI) or concussion can precipitate a lifelong degenerative process in the brain. The findings of this study, led by Dr. Fiona Crawford and conducted by...

This year’s Veterans Day event was a smashing success and we’d like to thank everyone who came out to visit and take part in making history.

The Roskamp Institute is pleased to announce that the first annual Grey Matters Symposium on Alzheimer’s Disease Research has sold out.

Stephen Harlin, M.D. FACS
The Harlin Center for Precision Medicine will present: A Precision Medicine Approach to Alzheimer’s Disease (AD)

A clinical application involves three key steps: 1) A genetic risk screening for the presence of specific mutations identified in gene-wide association (GWA) studies as playing a pathogenic role. 2) Detection of disease-associated abnormalities as early as possible (even preceding symptoms). 3) Prescription of explicit health-promoting interventions aimed at an individual’s molecular drivers of disease.